The role of antepartum transabdominal amnioinfusion in the management of oligohydramnios in pregnancy

Butt, Fatima T.; Ahmed, Badreldeen

doi:10.3109/14767058.2010.497574

Cited by 11 publications

(10 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly Locatelli et al, Jung et al, Fatima T Butt et al and GJ Kim et al, also noted a significant increase in latency period. [12][13][14][15] In our study, 27.8% of patients needed caesarean section which was comparable to various studies like Patrizia Vergani et al calculated rate of LSCS 5% in study group and Chhabra et al calculated rate of LSCS 18% in the study group. 16,17 Similarly Mandelbrot et al also reported a significant decrease in rate of caesarean sections in the amnioinfused group.…”

Section: Discussionsupporting

confidence: 76%

See 1 more Smart Citation

Therapeutic amnioinfusion in oligohydramnios during pregnancy (excluding labor)

Qazi

Saqib

Ahmad

et al. 2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Oligohydramnios is a serious complication of pregnancy that is associated with a poor perinatal outcome and complicates 1-5% of pregnancies. The purpose of this study was to evaluate the role of antepartum transabdominal amnioinfusion on amniotic fluid volume/latency period in pregnancies with oligohydramnios.Methods: This study was conducted in the Department of Obstetrics and Gynaecology at Sher-i-Kashmir Institute of Medical Sciences Soura Srinagar. In this study, a total of 54 pregnant women with ultrasonographically diagnosed oligohydramnios i.e. AFI < 5 cm and gestational age of >24 weeks were taken for therapeutic amnioinfusion and its effects on amniotic fluid volume were studied. Statistical Software SPSS (Version 20.0) and Microsoft excel were used to carry out the statistical analysis of data. P-value less than 0.05 was considered statistically significant.Results: Mean age of patients in our study was 27.5±3.19 years and gestational age group of 28-34 weeks. The mean AFI pre and post amnioinfusion was found to be 3.3 cm and 8.8 cm respectively. The difference was found to be statistically significant with a p value of <0.001. There was increase in the latency period in the studied patients with a mean latency period of 42.8±14.94 days. Mean number of transabdominal amnioinfusions in our study was 1.48±0.64. In our study, majority of patients i.e. 33 (61.1%) delivered at 38-40 weeks with a mean age at delivery 37.4±1.92 weeks. In our study, maximum number of patients i.e. 32 (59.3%) were delivered by full term normal delivery and only 15 (27.8%) required caesarean section. 78% of newborns weighed >2.5kg. The mean weight of newborn was 2.9±0.59 kgs. The incidence of newborn admissions to NICU was 20.4%. Number of neonatal deaths in our study was 5.6%. There was reduction of neonatal admission to NICU and neonatal deaths after transabdominal amnioinfusion.Conclusions: Antepartum transabdominal amnioinfusion is a useful procedure to reduce complications resulting from decreased intra-amniotic volume. It significantly raises the amniotic fluid especially useful in preterm pregnancies, where the procedure allows for a better perinatal outcome by significantly prolonging the duration of pregnancy, increasing birth weight, preventing fetal distress and thereby reducing operative intervention. Optimizing the selection of patients who are good candidates for the procedure is a prerequisite.

show abstract

Section: Discussionsupporting

confidence: 76%

“…In the study conducted by Fatima T Butt et al, mean number of infusions was 1.05 per pregnant women. 14 In present study, there was a significant increase in latency period in patients in whom TAA was performed. Mean Latency period was 42.8±14.94 days.…”

Section: Discussionmentioning

confidence: 63%

Therapeutic amnioinfusion in oligohydramnios during pregnancy (excluding labor)

Qazi

Saqib

Ahmad

et al. 2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

show abstract

“…There is insufficient evidence to guide clinical practice concerning the use of amnioinfusion for PPROM (23). However, recent studies seem to support amnioinfusion in the management of PPROM, although the sample sizes have been small (24,25). Our experience has been that the infused fluid often leaks out and amniotic fluid volume is not restored as expected.…”

Section: Discussionmentioning

confidence: 99%

Aggressive intervention of previable preterm premature rupture of membranes

Miyazaki

Furuhashi

Yoshida

et al. 2012

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

show abstract

“…The other cases must be individualized, considering that the fetus with growth restriction is more susceptible to sudden changes in the uterine-placental flow, with higher risk of hypoxia, acidosis, meconium and intrapartum death. In addition, in the presence of oligohydramnios, severe and frequent umbilical decelerations may occur during labour; in such cases, aminoinfusion may be performed, bringing the benefits reported in the literature [75].…”

Section: Managementmentioning

confidence: 95%